Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10.
Design of a bioactive small molecule that targets r(AUUCU) repeats in spinocerebellar ataxia 10.
复制标题
DOI:
10.1038/ncomms11647
复制
发表时间:
2016-06-01
影响因子:
16.6
通讯作者:
Disney MD
中科院分区:
文献类型:
--
作者:
Yang WY;Gao R;Southern M;Sarkar PS;Disney MD
RNA is an important target for chemical probes of function and lead therapeutics; however, it is difficult to target with small molecules. One approach to tackle this problem is to identify compounds that target RNA structures and utilize them to multivalently target RNA. Here we show that small molecules can be identified to selectively bind RNA base pairs by probing a library of RNA-focused small molecules. A small molecule that selectively binds AU base pairs informed design of a dimeric compound (2AU-2) that targets the pathogenic RNA, expanded r(AUUCU) repeats, that causes spinocerebellar ataxia type 10 (SCA10) in patient-derived cells. Indeed, 2AU-2 (50 nM) ameliorates various aspects of SCA10 pathology including improvement of mitochondrial dysfunction, reduced activation of caspase 3, and reduction of nuclear foci. These studies provide a first-in-class chemical probe to study SCA10 RNA toxicity and potentially define broadly applicable compounds targeting RNA AU base pairs in cells. Expanded RNA repeats in non-coding region of a gene represent a hallmark of several diseases. Here, the authors identify two small molecules that selectively bind AU repeats and use them to design a compound that targets the pathogenic RNA associated with spinocerebellar ataxia type 10.